Announcement
07 Jan 2021
In January 2021, the Norwegian authorities introduced an export ban on certain rivaroxaban and salmeterol following the outbreak of COVID-19.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
07 Jan 2021
Revocation date:
28 Jan 2021
On 7 January 2021, the Norwegian Medicines Agency introduced an export ban on certain rivaroxaban and salmeterol. The export bans were introduced due to concerns of shortages following the outbreak...
See all
This state act is not part of any Thread yet.